Delivery Order SPE2DB20D7066-SPE2DB25FC4VH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (300mL) with a ceiling value of $1,154.53. This competitively awarded, firm fixed-price contract was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of a 300 ml oral suspension medication, KONVOMEP 2-84 MG/ML, valued at $2,783.76. This order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,701.73 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Konvomep 2-84 mg/mL oral suspension in a 300mL volume. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The contract is to be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for the supply of Konvomep 2-84 mg/mL oral suspension in a 300 mL quantity, with a firm fixed price ceiling value of $1,427.88. This non-competitive delivery order, which has an ultimate completion date of September 11, 2025, falls under the Medical Supply Chain division of the Department of Defense. The award represents a child contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The order is for the supply of 300 ml oral suspension of the drug KONVOMEP 2-84 mg/ml, with a ceiling value of $6,729.12 and a period of performance through April 9, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $4,393.65, is for the delivery of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, with a ceiling value of $1,332.16 and a period of performance through July 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a firm fixed price delivery order contract worth $9,294.58 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has a firm fixed-price of $3,612.42 and a completion date of May 27, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $6,312.96, is for a delivery order of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of December 23, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4VHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Konvomep 2-84 mg/mL oral suspension (150 mL) with a firm fixed price ceiling value of $1,332.16. This non-set-aside competitive award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and other critical medical commodities. Through this contract vehicle, the company supports multiple government healthcare systems, including the Defense Health Agency and U.S. Coast Guard, positioning it as a key pharmaceutical distributor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/18/25 |